The goal of this interventional study (clinical trial) is to check if ajwa seed powder can treat type 2 diabetes mellitus in overweight and and obese patients with type 2 diabetes mellitus including both male and female of the age group between 30-50. The main question is what would be the impact of ajwa seed powder on HbA1c and body composition in overweight and obese patients with type 2 diabetes mellitus which aim to
result in better glycemic control particular Hba1c, and body composition improvement in type 2 diabetes mellitus patients
Participants will be asked to consume 4 grams of ajwa seed powder per day
Age: 30-50 years
Gender: Male/female
Body Mass Index (BMI): 25-35 kg/m²
Type 2 diabetes mellitus: HbA1c ≥ 6.5%
Patients being treated with insulin
High initial levels of serum creatinine (men>1.5 mg/dl; women>1.2 mg/dl)
Pregnant/lactating females or women who cannot take proper contraceptive measures
Symptoms consistent with peptic ulcer disease or history of peptic ulcers